Beijing Chunlizhengda Medical Instruments Co Ltd (688236) — Net Asset Quality Index
Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has a Net Asset Quality Index of 84.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.54 Billion minus total liabilities of CN¥554.08 Million yields net assets of CN¥2.99 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Beijing Chunlizhengda Medical Instrument's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Beijing Chunlizhengda Medical Instruments Co Ltd Net Asset Quality Index Over Time (2012–2024)
This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 84.3%, representing net assets of CN¥2.99 Billion against total assets of CN¥3.54 Billion CNY. See working capital to net assets of Beijing Chunlizhengda Medical Instrument to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Beijing Chunlizhengda Medical Instrument.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 81.4% | CN¥2.82 Billion | CN¥3.47 Billion | CN¥644.39 Million | ▲ +2.5 pp |
| 2023 | 78.9% | CN¥2.88 Billion | CN¥3.65 Billion | CN¥770.33 Million | ▼ -0.9 pp |
| 2022 | 79.8% | CN¥2.72 Billion | CN¥3.41 Billion | CN¥690.07 Million | ▼ -2.5 pp |
| 2021 | 82.3% | CN¥2.47 Billion | CN¥3.00 Billion | CN¥530.58 Million | ▲ +12.2 pp |
| 2020 | 70.1% | CN¥1.08 Billion | CN¥1.54 Billion | CN¥460.41 Million | ▲ +3.4 pp |
| 2019 | 66.7% | CN¥806.59 Million | CN¥1.21 Billion | CN¥402.72 Million | ▼ -10.4 pp |
| 2018 | 77.1% | CN¥628.14 Million | CN¥814.74 Million | CN¥186.60 Million | ▼ -7.9 pp |
| 2017 | 85.0% | CN¥538.47 Million | CN¥633.66 Million | CN¥95.19 Million | ▼ -4.1 pp |
| 2016 | 89.0% | CN¥480.91 Million | CN¥540.13 Million | CN¥59.22 Million | ▲ +0.4 pp |
| 2015 | 88.6% | CN¥423.56 Million | CN¥478.04 Million | CN¥54.49 Million | ▲ +2.8 pp |
| 2014 | 85.9% | CN¥205.92 Million | CN¥239.86 Million | CN¥33.94 Million | ▼ -3.8 pp |
| 2013 | 89.7% | CN¥179.89 Million | CN¥200.63 Million | CN¥20.74 Million | ▼ -2.7 pp |
| 2012 | 92.4% | CN¥173.17 Million | CN¥187.51 Million | CN¥14.34 Million | — |